⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Emmes Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Emmes Group
↗Rockville, Maryland, USA
Emmes is a global, tech-enabled, full-service clinical research organization (CRO) founded in 1977. The company specializes in supporting biopharmaceutical, government, non-profit, and academic partners in advancing human health through clinical trials, regulatory affairs, data management, and AI-powered solutions.
Emmes distinguishes itself as a specialty CRO with deep expertise in complex therapeutic areas, including vaccines, infectious diseases, ophthalmology, oncology, neuroscience, rare diseases, and cell and gene therapy. The company leverages a proprietary technology and AI platform (Veridix) to automate clinical trial workflows, aiming to accelerate drug development timelines and improve data quality.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1977
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Investors:New Mountain Capital, Behrman Capital
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Cell therapy, Gene therapy, Vaccines
Active Trials:2150
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:New Mountain Capital
Acquired By:New Mountain Capital (2022-06-01)
Subsidiaries:Orphan Reach, Emmes Canada (Emmes CRO Services ULC), Veridix AI, VaxTrials
Key Partnerships:National Institutes of Health (NIH), National Cancer Institute (NCI), Gates Foundation, PATH, IAVI
COMPETITION
Position:Leader
Competitors:Cytel, IQVIA, PPD, Parexel, ICON
LEADERSHIP
Key Executives:
Christine Dingivan - CEO
LINKS
Website:emmes.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Emmes Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.